PETRUCCI, GIOVANNA
 Distribuzione geografica
Continente #
AS - Asia 350
NA - Nord America 324
EU - Europa 79
SA - Sud America 63
AF - Africa 10
Totale 826
Nazione #
US - Stati Uniti d'America 308
CN - Cina 121
SG - Singapore 101
HK - Hong Kong 66
BR - Brasile 42
EE - Estonia 40
IT - Italia 17
VN - Vietnam 14
MX - Messico 12
AR - Argentina 6
IN - India 6
SA - Arabia Saudita 6
PH - Filippine 5
PK - Pakistan 5
TR - Turchia 5
BD - Bangladesh 4
FR - Francia 4
VE - Venezuela 4
DE - Germania 3
ES - Italia 3
ID - Indonesia 3
NP - Nepal 3
PE - Perù 3
CA - Canada 2
CL - Cile 2
EC - Ecuador 2
GB - Regno Unito 2
MA - Marocco 2
MY - Malesia 2
RU - Federazione Russa 2
UA - Ucraina 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 826
Città #
San Jose 233
Hong Kong 65
Ashburn 59
Singapore 54
Beijing 43
Tallinn 40
São Paulo 8
Rome 7
Mexico City 6
Hanoi 5
Ho Chi Minh City 4
Santa Clara 4
Istanbul 3
Jeddah 3
Modena 3
Buenos Aires 2
Dresden 2
Lahore 2
Montevideo 2
Prato 2
Rabat 2
Rio de Janeiro 2
Riyadh 2
Salvador 2
Abuja 1
Addis Ababa 1
Aire-sur-la-Lys 1
Al Ain City 1
Amiens 1
Arequipa 1
Baguio City 1
Bandung 1
Barra Bonita 1
Belém 1
Benito Juarez 1
Bexley 1
Bắc Ninh 1
Calamba 1
Cameri 1
Campeche 1
Campo de Carabobo 1
Cape Town 1
Caracas 1
Cardiff 1
Carmo do Cajuru 1
Carneiros 1
Celaya 1
Chernivtsi 1
Chisinau 1
Chía 1
Conselheiro Lafaiete 1
Coro 1
Corrientes 1
Council Bluffs 1
Craiova 1
Curicó 1
Da Nang 1
Dammam 1
Denia 1
Dhaka 1
Du Quoin 1
Duque de Caxias 1
El Jagüel 1
Estância 1
Fortaleza 1
Frankfurt am Main 1
Germantown 1
Girau do Ponciano 1
Guatemala City 1
Guayaquil 1
Gunpo 1
Haiphong 1
Hamad Town 1
Iloilo City 1
Imperatriz 1
Itatiaiuçu 1
Itatiba 1
Itatinga 1
Iztapalapa 1
Jakarta 1
Jessore 1
Juiz de Fora 1
Kathmandu 1
Kayseri 1
Kirov 1
Kolkata 1
Kozhikode 1
Kuala Lumpur 1
Langhus 1
Lima 1
Los Andes 1
Luanda 1
Luhansk 1
Luque 1
Macon 1
Madrid 1
Manchester 1
Mandaguaçu 1
Melun 1
Milan 1
Totale 631
Nome #
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 63
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 36
Stability of the thromboxane B2 biomarker of aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 27
Tumorigenic Potential of Olfactory Bulb-Derived Human Adult Neural Stem Cells Associates with Activation of TERT and NOTCH1 27
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 23
Telomerase inhibition impairs tumor growth in glioblastoma xenografts 20
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 20
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 19
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 19
Long-term pharmacodynamic and clinical effects of twice-daily low-dose aspirin in patients with essential thrombocythemia: results from the ARES randomized phase-2 trial 18
Very-Low-Dose Twice-Daily Aspirin Maintains Platelet Inhibition and Improves Hemostasis during Dual-Antiplatelet Therapy for Acute Coronary Syndrome 18
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note 16
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 16
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 16
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 15
Mesenchymal differentiation of glioblastoma stem cells 15
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 14
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 14
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 14
. Effect of low-dose rivaroxaban with low-dose aspirin vs. low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease 13
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation 13
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 13
Distinct expression of cyclooxygenase-1 and -2 in the human thymus 13
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 13
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 12
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 12
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 12
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 11
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 11
Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial 11
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 11
Poor responsiveness to low-dose aspirin contributes to persistent in vivo platelet activation in polycythemia vera 11
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 11
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 11
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 10
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 10
Mesenchymal differentiation of glioblastoma stem cells 10
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance 10
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 10
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 10
In Vivo Platelet Activation In Impaired Glucose Tolerance And During Progression Of Type 2 Diabetes: A Cross-sectional And Longitudinal Study 10
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 9
prostaglandin E2 and EP3 activation potentiate human platelet responsiveness 9
Platelet Thromboxane Inhibition by Low-Dose Aspirin in Polycythemia Vera: Ex Vivo and In Vivo Measurements and In Silico Simulation. 9
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 9
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 9
Pathophysiology of Thrombosis in Peripheral Artery Disease 9
Effect of cyclooxygenase-2 (COX-2) delection on megakaryopoiesis and peripheral platelet phenotype 9
Variability in the recovery rate of platelet cyclooxygenase activity during chronic therapy with low-dose aspirin in type 2 diabetes 9
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 9
Kinetics of 24-hour recovery of platelet TXA2 production: a methodological approach to describe and understand variability in low-dose aspirin response 8
In Vivo Platelet Activation And Aspirin Responsiveness In Type 1 Diabetes Mellitus 8
Effect of Low-dose and Standard-dose Aspirin on PGE 2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial 8
the Contribution of COX-1 and COX-2 to platelet activation in Essential Thrombocythemia: a clinical paradigm of aspirin-resistant thromboxane biosynthesis 8
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 8
Variable antiplatelet response to thyenopiridines: should we use lab tests? 8
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 8
Insulin Resistant Mice Lacking p66Shc Gene are Protected Against Endothelial Dysfunction 8
Platelet and megakaryocyte phenotypes of COX-2 deletion 8
Tumorigenic potential of olfactory bulb derived human adult neural stem cells associates whit activation of TERT and NOTCH1. 8
VON WILLEBRAND FACTOR CHANGES IN ESSENTIAL THROMBOCYTHEMIA. ITS ROLE IN THROMBO-HAEMORRHAGIC COMPLICATIONS. 8
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 7
Aspirin, stroke and drug-drug interactions 7
Farmaci Antipiastrinici 7
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 7
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 7
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 7
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial 7
Von Willebrand factor levels in polycythemia vera are not reduced and can be predicted by erythrocyte counts 6
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 5
Totale 887
Categoria #
all - tutte 2.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202581 0 0 0 40 0 0 1 9 0 0 17 14
2025/2026806 8 1 18 33 56 54 98 97 356 85 0 0
Totale 887